OXYGENTA PHARMACEUTICAL
Back to Balance Sheet
|
OXYGENTA PHARMACEUTICAL Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹73 Cr | ₹54 Cr | ₹54 Cr | ₹31 Cr | ₹34 Cr |
What is the latest Total Liabilities ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹73 Cr |
| Mar2024 | ₹54 Cr |
| Mar2023 | ₹54 Cr |
| Mar2022 | ₹31 Cr |
| Mar2021 | ₹34 Cr |
How is Total Liabilities of OXYGENTA PHARMACEUTICAL Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹73 Cr | 33.35 | |
| Mar2024 | ₹54 Cr | 0.36 | |
| Mar2023 | ₹54 Cr | 74.06 | |
| Mar2022 | ₹31 Cr | -7.94 | |
| Mar2021 | ₹34 Cr | - | |
Compare Total Liabilities of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹185.6 Cr | -3.6% | -13.5% | -34.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,693.0 Cr | -1.7% | 4% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,270.0 Cr | -4.7% | -1.8% | 10.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,281.0 Cr | -3.7% | 4.5% | 42.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,422.0 Cr | -3% | 0% | 15.4% | Stock Analytics | |
| CIPLA | ₹104,915.0 Cr | -2.6% | -2.3% | -10.1% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -3.6% |
-13.5% |
-34.2% |
| SENSEX | -2.7% |
-10.4% |
1.6% |
You may also like the below Video Courses